All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank
CN
中文 English

Early Drug Discovery and Screening

It enables customers to precisely identify and optimize “seed” compounds or biomacromolecules with development potential.

Target validation: Customized cell models are established using cutting-edge gene-editing technologies such as CRISPR/Cas9 and RNAi, enabling in-depth assessment of the feasibility of specific genes or proteins as therapeutic targets.

Library Screening: We offer high-throughput screening (HTS) and high-content screening (HCS) services, enabling rapid identification of active lead compounds from small-molecule libraries, natural product collections, or high‑throughput CRISPR mutant libraries, thereby accelerating early‑stage target validation and drug discovery.

Drug Property Design and Optimization: Leveraging Computer-Aided Drug Design (CADD), medicinal chemistry, and…